Merrill Lynch Dividend Yield Stocks to Buy

Photo of Lee Jackson
By Lee Jackson Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

With a general consensus that at some point this year, maybe as soon as this summer, interest rates are poised to rise, owning dividend yield stocks is a somewhat contrarian idea. In a new and wide-ranging report from Bank of America Merrill Lynch, one of the firm’s contrarian ideas is just that, owning dividend yield stocks. Another idea is owning large cap stocks, which some have said should be sold in favor of more domestic-oriented stocks, like small and mid-cap companies.

We combined the two Merrill Lunch ideas that secular contrarians should be long, or own now, and screened the Merrill Lynch stocks universe for large-cap dividend yield stocks that are rated Buy at the firm. We found five top stock to buy, all of which yield an almost a full percentage point more than the 10-year Treasury.

Altria Group Inc. (NYSE: MO) is a top tobacco stock to buy on Wall Street, and its Marlboro brand is one of the most recognizable in the world. The company has solid downside support owing to the generous dividend yield, which remains at a huge premium in relation to the 10-year Treasury rate. Cash flow generation and the return of cash to Altria shareholders remain key facets of the company’s total shareholder return, and the analysts expect support of the strong dividend, which they believe will continue to climb. The company recently reaffirmed solid 2015 guidance at the Consumer Analyst Group of New York Conference.

Altria shareholders are paid a 3.80% dividend. The Merrill Lynch price target for the stock is $60. The Thomson/First Call consensus price target is $56.78. Altria closed Monday at $55.51 a share.

ALSO READ: 3 Must-Own Cybersecurity Software Stocks

General Motors Co. (NYSE: GM) is a top automobile maker that is rated as a Buy at Merrill Lynch. Despite all the recall troubles, hedge funds and mutual funds are continuing to stick with the company, as many view the stock as very undervalued. GM trades at a low 8.4 times estimated 2015 forward earnings. Like Ford, it has benefited from incredible sales in China to boost revenue. GM invested heavily in China decades ago and grabbed a big chunk of what is now the world’s largest auto market. The company sold 3.16 million vehicles in 2013, which was an increase of 11%, and right at 3.5 million last year.

GM investors are paid a very respectable 3.2% dividend. The Merrill Lynch price target is $51. The consensus target is lower at $41.81. GM closed Monday at $37.69.

Pfizer Inc. (NYSE: PFE) is one of the most popular health care stocks among hedge funds. After a very slow 2014, the stock is up almost 10% this year, despite a so-so fourth-quarter earnings report. Pfizer recently announced a gigantic $15.2 billion purchase of Hospira, a top provider of sterile injectable drugs — including those used for acute care and cancer treatment — infusion technologies and biosimilars, which are subsequent versions of drugs whose patents have expired. In other recent solid news for Pfizer, the company’s drug Ibrance was approved for advanced breast cancer by U.S. regulators more than two months ahead of schedule, letting the drug maker proceed with one of its most promising new blockbusters.

Pfizer investors are paid a solid 3.25% dividend. The Merrill Lynch price target is $36, and the consensus price objective is $35.83. The stock closed Monday at $34.39.

ALSO READ: 5 Energy Buyout Candidates as Oil Plunge Continues

Procter & Gamble Co. (NYSE: PG) is a solid consumer staples stock for investors to consider. The company sells lots of run-of-the-mill household items that are essential for everyday life. It is not content to stand pat on its laurels. P&G actually is innovative in its product development process and uses that to help ensure future growth and cash flow. This should provide investors years of steady growth and dividends. While currency headwinds have weighed on recent earnings and projections, the dollar may be topping out and that would bode well for the future.

Shareholders are paid a 3.02% dividend. Merrill Lynch has a $95 price target, a touch higher than the $93.21 consensus target. The stock closed Monday at $85.39 a share.

Verizon Communications Inc. (NYSE: VZ) is a top telecommunications company to Buy at Merrill Lynch, and it is also on the firm’s US 1 list. Verizon offers investors consistent and steadily growing dividends. The company recently purchased $10.4 billion worth of new spectrum during the recent government auctions, and it is planning to continue to expand and improve the company’s 4G LTE network, which it bills as the nation’s largest and best.

Verizon investors are paid an outstanding 4.5% dividend. The Merrill Lynch price target is $55, while the consensus target is $51.50. The stock closed Monday at $48.77.

ALSO READ: 5 Well-Known Technology Buyout Candidates

While none of these top blue chips really seem like contrarian calls, they actually have been somewhat neglected for the hot tech and biotech companies. They give investors solid total return upside potential and should hold up better when the market takes the next big downturn.

Photo of Lee Jackson
About the Author Lee Jackson →

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad and diverse career, which included a stint as the creative services director at the NBC affiliate in Austin, Texas, gives him unique insight into the financial industry and world.

Lee Jackson's journey in the financial industry spans over 30 years, with nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career was marked by his presence on the sell side during pivotal Wall Street events, from the dot.com rise and bubble to the Long Term Capital Management debacle, 9/11, and the Great Recession of 2008. This is a testament to his resilience and adaptability in the face of market volatility.

Lee Jackson’s practical financial industry experience, acquired from a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing on various platforms. This unique combination allows him to shed light on the intricacies and workings of Wall Street in a way that only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SBAC Vol: 6,563,665
INTC Vol: 116,894,024
CCI Vol: 6,078,125
DASH Vol: 5,051,322
GLW Vol: 11,572,082

Top Losing Stocks

ENPH Vol: 6,441,768
TSLA Vol: 82,993,122
GE Vol: 5,322,694
LKQ
LKQ Vol: 4,320,256
SWK Vol: 2,144,540